Cardiology and Cardiac Surgery (ICCCS-27)

This track will explore the latest advancements in the diagnosis and management of acute coronary syndromes. Emphasis will be placed on innovative therapeutic strategies and clinical outcomes.

This session will focus on the latest research and technological advancements in cardiac electrophysiology. Topics will include arrhythmia management, device therapy, and novel ablation techniques.

This track will address the complexities of adult congenital heart disease, including diagnosis, treatment, and long-term management. Case studies and emerging therapies will be highlighted.

This session will delve into the mechanisms underlying heart failure, including diastolic dysfunction and its clinical implications. New pharmacological and non-pharmacological treatment options will be discussed.

This track will cover advanced imaging modalities such as MRI, echocardiography, and CT in the assessment of cardiovascular diseases. The role of imaging in guiding treatment decisions will be emphasized.

This session will focus on the diagnosis and management of arterial occlusive diseases and thrombosis. Innovative surgical and non-surgical interventions will be explored.

This track will highlight recent developments in pediatric cardiology, including interventions for congenital heart defects and cardiomyopathies. The importance of multidisciplinary approaches in pediatric care will be discussed.

This session will examine the relationship between cardiovascular health and cerebrovascular disorders, including stroke. Prevention strategies and management protocols will be a focal point.

This track will address the pathophysiology of hypertension and its role in cardiovascular disease. Current guidelines and treatment strategies will be reviewed.

This session will explore the latest surgical techniques in cardiovascular surgery, including valve repair and coronary artery bypass grafting. Outcomes and patient selection criteria will be discussed.

This track will focus on novel pharmaceutical agents in the treatment of cardiac conditions, including heart failure and arrhythmias. The implications of these therapies for clinical practice will be evaluated.